Table 3

Studies of metabolic syndrome in diabetes in hospital settings across Africa

Metabolic syndrome (%)
StudyCountryYear publishedSampleSettingAgeDurationCriteriaOverallMenWomen
Longo-Mbenza45DRC20101266Urban50IDF27.1
Kengne47Cameroon2012308Urban55.83.0IDF71.75886.1
Cameroon2012308Urban55.83.0NCEP60.442.778.8
Alshkri60Libya200899Urban569.4NCEP928297
Libya200899Urban569.4IDF816888
Libya200899Urban569.4NCEP60.442.778.8
Ogbera50Nigeria2010973Urban58.66.9JIS868387
Unadike61Nigeria2009240Urban50.8NCEP62.541.579.1
Adediran62Nigeria2007408Urban56WHO514456
Isezuo63Nigeria2005254Urban526.1WHO59
Alebiosu64Nigeria2004218Urban53.48.5WHO25.22525.6
Puepet65Nigeria2009634Urban54.2IDF63.674.554.9
Kelliny46Seychelles2008130Nationwide25–64NCEP66.887.1
Seychelles2008130Nationwide25–64WHO85.579.7
Seychelles2008130Nationwide25–64IDF7493
Kalk66South Africa (black)2008500Urban48.32.0IDF50.246.574.1
South Africa (white)2008254Urban54.16.0IDF73.652.973.1
Makuyana67Zimbabwe2004109UrbanWHO43
  • IDF, International Diabetes Federation; JIS, Joint Interim Statement; NCEP, National Cholesterol Education Program, Adult Treatment Panel III.